Sign in to view content

Baseline Factors Associated With 1-Year Outcomes in Phase III Comparison of SB11 (Approved Ranibizumab Biosimilar) With Reference Ranibizumab in nAMD

Neil M. Bressler, MD

Video
Published 2022

Related

Juxtafoveal Choroidal Neovascularization in Pediatric Patients: A Case Series
Andres Emanuelli, MD
On Demand Cases, Courses, and Papers
2017
Episode 119: 2018 ASRS Annual Meeting Post-Mortem Including Protocol S 5-Year Results
Jayanth Sridhar, MD
Member Podcasts
2018
Unsupervised Deep Learning for Grading Age-Related Macular Degeneration Using Retinal Fundus Images
Neesurg S Mehta, MD
On Demand Cases, Courses, and Papers
2021

Category: AMD-Neovascular

See more